Printer Friendly
The Free Library
5,668,249 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Research and Markets: Egis Reported Total Sales in Fiscal Year 2005 Worth HUF72,959.9 Million (US$377.2 Million).


DUBLIN Dublin, city, Republic of Ireland
Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River.
, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c45973) has announced the addition of "Egis Generics Company Intelligence Report" to their offering.

Egis was established in Budapest, Hungary, in 1913. The company has three manufacturing sites: two in Budapest, and one at KErmend, near the border with Austria.

The company has 18 subsidiaries under its direct control. Six are in Hungary, with the remaining 12 abroad. Additionally, Egis has seven indirect subsidiaries, all of which are in Hungary, and 20 representative offices across the world.

Egis has been listed on the Budapest Stock Exchange Budapest Stock Exchange

Established in 1864, the major securities market of Hungary.
 since 1994. However, Hungarian investors only make up around 6% of its ownership. The majority owner is the French firm, Servier, which has 51% of Egis' shares. Egis acts as a distributor for Servier in Hungary, and supplies generics to France through Servier's generic subsidiary. It also markets products through Servier's subsidiaries in the United Kingdom.

Egis reported total sales in fiscal year 2005 worth HUF HUF

In currencies, this is the abbreviation for the Hungarian Forint.

Notes:
The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion.
72,959.9 million (US$377.2 million). This was an increase of 10% over fiscal year 2004, when sales were worth HUF66,107.6 million. Net income reached HUF11,384.2 million (US$58.6 million), over 54% higher than a year earlier.

Exports accounted for HUF43,216 million (US$223.4 million), or 59% of Egis' total sales. Outside of Hungary, the company's largest markets are those of Russia and the CIS Cis (sĭs), same as Kish (1.)


(1) (CompuServe Information Service) See CompuServe.

(2) (Card Information S
, and Central and Eastern Europe The term "Central and Eastern Europe" came into wide spread use, replacing "Eastern bloc", to describe former Communist countries in Europe, after the collapse of the Iron Curtain in 1989/90. .

These generics company reports from Espicom will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into the company, covering the structure of the business, the most recent quarterly and annual financial results, information on the company's active product lines and ANDA ANDA
abbr.
abbreviated new drug application
 approvals, along with a review of major developments, such as M&A activity, strategic alliances, and litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute.

When a person begins a civil lawsuit, the person enters into a process called litigation.
.

The easy and cost effective way to monitor developments in leading generic drug generic drug, a drug sold or prescribed under the nonproprietary name of its active ingredients or under a generally descriptive name rather than under a brand or trade name.  industry players.

Generics Company Reports are packed with facts, figures and statistics, providing you with the most thorough ongoing monitoring of the important generic companies. From financial performance to litigation, no other service provides such comprehensive insight to the companies driving growth in this rapidly expanding area of the pharmaceutical industry.

Each report is updated and issued every quarter. This ongoing monitoring and regular delivery ensures that developments are incorporated into the relevant reports. This vigilance VIGILANCE. Proper attention in proper time.
     2. The law requires a man who has a claim to enforce it in proper time, while the adverse party has it in his power to defend himself; and if by his neglect to do so, he cannot afterwards establish such claim, the
 ensures that whether it's the latest deals, ANDAs, alliances or litigation you can assess the impact of the development in the context of the company, its competitors and the broader market.

Use Generic Company Reports to:

* Evaluate the competitive operating environment In computing, an operating environment is the environment in which users run programs, whether in a command line interface, such as in MS-DOS or the Unix shell, or in a graphical user interface, such as in the Macintosh operating system. .

* Identify which companies are applying for ANDAs, and for what.

* Understand generic companies' product line up.

* Monitor the financial performance of leading generics players.

* Track the twists and turns of litigation.

Stay in touch with the latest M&A and strategic alliances

Topics Covered:

* Products

* Financial results

* Major developments

For more information visit http://www.researchandmarkets.com/reports/c45973

Source: Espicom
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 27, 2006
Words:504
Previous Article:Research and Markets: With More Than Two Million Units Deployed In 150 Countries, Alavarion Ltd Is A Leader In Providing Wireless Broadband Systems.
Next Article:Compare The Average Performance of Power, Gas, and Integrated Power and Gas Utilities across Europe.



Related Articles
Who are the Winners and Losers in the Global Pharmaceutical Industry?
Prosoft Learning Corporation Reports First Quarter Results.
NaviSite Reports Second Quarter Fiscal Year 2006 Results.
Pharmaceutical Production in Hungary is Specialised in the Production of Generic Drugs with Nearly 20 Original Molecules Developed During the Last...
Imagenetix Reports First Fiscal Quarter Results.
C-COR Reports Financial Results for Fourth Quarter and Fiscal Year 2006.
From July 2005 - June 2006, the Total Sales of Pharma Products Went up by 14.5% to RON 4.9Bn (EUR 1.39Bn).
D.R. Horton, Inc., America's Builder, Reports Fourth Quarter and Fiscal Year 2006 Results.
The 2006 Pharmaceutical Companies Performance Tables Contains Detailed Performance Rankings for More Than 100 Leading Pharmaceutical Companies.
Research and Markets: Egis Reported Total Sales in Fiscal Year 2005 Worth US$377.2 million.(Financial report)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles